Kusajili – Clinical trials directory

Result of your search per sponsor: Merck Generics UK Ltd

Woman and Man Max 99 years
Merck Generics UK Ltd Update Il y a 4 ans

A CUMULATIVE DOSE RESPONSE STUDY TO EVALUATE THE THERAPEUTIC EQUIVALENCE OF A NEW SALMETEROL INHALATION AEROSOL CONTAINING A REPLACEMENT HFA PROPELLANT IN A PRESSURISED METERED DOSE INHALER AND EXISTING SALMETEROL–CFC PRODUCT The primary aim of the study is: To assess the therapeutic equivalence of a new salmeterol HFA-134a formulation compared to a reference salmeterol CFC formulation given in a cumulative dose design.

Country None
organs None
Specialty None

unknown

More information